| Literature DB >> 35643459 |
Rami Mizuta1, Noriaki Maeda1, Makoto Komiya1, Yuta Suzuki2, Tsubasa Tashiro1, Kazuki Kaneda1, Shogo Tsutsumi1, Honoka Ishihara1, Sayo Kuroda1, Yukio Urabe3.
Abstract
BACKGROUND: Experiencing perimenstrual symptoms is a major health concern for young women. Women in the reproductive age experience menstruation about once a month, and many experience perimenstrual symptoms. Drug therapies such as painkillers (commonly used) and hormonal medications help to achieve symptomatic relief from perimenstrual symptoms. However, many women are concerned about tolerance and compliance of the drugs used to treat perimenstrual symptoms and lack awareness on how to cope with perimenstrual symptoms. If the association between exercise habits and the severity of symptoms is emphasized in young women, methods for coping with perimenstrual symptoms can be established, not relying only on pharmaceuticals. The objective of this study was to determine the differences in the severity of perimenstrual symptoms in young Japanese women with and without a regular exercise habit.Entities:
Keywords: Dysmenorrhea; Exercise habit; Japanese; Lifestyle; Menstruation; Non-pharmacological coping strategy; Perimenstrual symptoms; Physical activity; Premenstrual syndrome; Young women
Mesh:
Year: 2022 PMID: 35643459 PMCID: PMC9148454 DOI: 10.1186/s12905-022-01720-2
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.742
Fig. 1Flowchart of study participants
Sociodemographic characteristics, lifestyle and physical activity between exercise and non-exercise group
| Characteristics of participants | Exercise group | Non-exercise group | χ2 | Effect size | |
|---|---|---|---|---|---|
| (n = 157) | (n = 120) | ||||
| Age (years) | 21.6 ± 1.9 | 21.9 ± 1.6 | 0.174 | 0.081 | |
| Age at menarche (years) | 12.5 ± 1.7 | 12.4 ± 1.5 | 0.286 | 0.029 | |
| BMI (kg/m2) | 20.7 ± 2.1 | 20.1 ± 2.0 | 0.067 | 0.109 | |
| Absence | 147 (93.6) | 120 (96.0) | 0.776 | 0.378 | 0.052 |
| Presence | 10 (6.4) | 5 (4.0) | |||
| Low | 146 (93.0) | 121 (96.8) | 2.002 | 0.157 | 0.084 |
| High | 11 (7.0) | 4 (3.2) | |||
| ≧ 7 h | 75 (47.8) | 59 (47.2) | 0.009 | 1.000 | 0.006 |
| < 7 h | 82 (52.2) | 66 (52.8) | |||
| Eating | 116 (73.9) | 87 (69.6) | 0.634 | 0.426 | 0.047 |
| Not eating | 41 (26.1) | 38 (30.4) | |||
| Eating | 115 (73.2) | 79 (63.2) | 3.273 | 0.070 | 0.108 |
| Not eating | 42 (26.8) | 46 (36.8) | |||
| Using | 75 (47.8) | 58 (46.4) | 0.052 | 0.819 | 0.014 |
| Not using | 82 (52.2) | 67 (53.6) | |||
| IPAQ-SF | |||||
| Low | 13 (28.3) | 80 (64.0) | 114.233 | 0.001* | 0.636 |
| Moderate | 92 (58.6) | 45 (36.0) | |||
| High | 52 (33.1) | 120 (0.0) |
Data are expressed as means ± SD, or n (%)
BMI body mass index, IPAQ-SF International Physical Activity Questionnaire Short Form
*Statistical significant
Comparison of MDQ scores between exercise and non-exercise groups
| Premenstrual | During menstruation | Postmenstrual | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exercise group | Non-exercise group | Effect size | Exercise group | Non-exercise group | Effect size | Exercise group | Non-exercise group | Effect size | ||||
| Total | 54.1 ± 19.1 | 60.2 ± 23.3 | 0.014* | 0.146 | 57.5 ± 19.3 | 68.4 ± 25.0 | < 0.001* | 0.231 | 41.7 ± 14.5 | 43.2 ± 16.0 | 0.358 | 0.055 |
| Pain | 10.0 ± 4.5 | 10.6 ± 4.8 | 0.237* | 0.070 | 12.2 ± 5.3 | 14.6 ± 6.0 | < 0.001* | 0.217 | 7.9 ± 4.0 | 8.0 ± 3.8 | 0.721 | 0.021 |
| Concentration | 10.0 ± 3.7 | 11.2 ± 5.0 | 0.047* | 0.118 | 10.5 ± 3.6 | 12.3 ± 5.2 | < 0.003* | 0.176 | 8.7 ± 2.2 | 9.2 ± 3.0 | 0.467 | 0.043 |
| Behavioral change | 9.1 ± 4.2 | 10.3 ± 5.2 | 0.040* | 0.122 | 10.0 ± 4.6 | 12.5 ± 5.6 | < 0.001* | 0.236 | 6.1 ± 2.6 | 6.7 ± 3.6 | 0.266 | 0.066 |
| Autonomic reaction | 4.6 ± 1.6 | 4.7 ± 1.6 | 0.380* | 0.052 | 5.1 ± 2.0 | 5.6 ± 2.5 | < 0.068* | 0.109 | 4.4 ± 1.7 | 4.4 ± 1.3 | 0.095 | 0.099 |
| Water retention | 8.2 ± 3.7 | 9.0 ± 3.7 | 0.049* | 0.117 | 7.6 ± 3.4 | 8.7 ± 3.7 | < 0.011* | 0.152 | 5.3 ± 2.6 | 5.6 ± 2.4 | 0.138 | 0.088 |
| Negative affect | 12.3 ± 5.9 | 14.5 ± 7.6 | 0.021* | 0.137 | 12.0 ± 4.8 | 14.7 ± 7.3 | < 0.003* | 0.179 | 9.2 ± 3.2 | 9.4 ± 3.7 | 0.911 | 0.007 |
Data are expressed as means ± SD
MDQ Menstrual Distress Questionnaire
*Statistical significant
Fig. 2Distribution of total premenstrual Menstrual Distress Questionnaire (MDQ) scores. Left: exercise group (n = 157), Right: non-exercise group (n = 125)
Fig. 3Distribution of total menstrual Menstrual Distress Questionnaire (MDQ) scores during menstruation. Left: exercise group (n = 157), Right: non-exercise group (n = 125)
Multiple logistic analysis for association of an exercise habit with premenstrual MDQ subscales
| Variables | β | SE | Wald | df | Odds ratio | 95% CI | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Concentration | − 0.012 | 0.047 | 0.064 | 1 | 0.800 | 0.988 | 0.902 | 1.083 |
| Behavioral change | − 0.003 | 0.050 | 0.003 | 1 | 0.956 | 0.997 | 0.905 | 1.099 |
| Water retention | − 0.016 | 0.040 | 0.173 | 1 | 0.678 | 0.984 | 0.910 | 1.063 |
| Negative affect | − 0.048 | 0.018 | 10.125 | 1 | 0.009* | 0.953 | 0.919 | 0.988 |
Variation inflation factor: concentration, 2.623; behavioral Change, 3.526; water retention, 1.451; negative affect, 2.920
MDQ Menstrual Distress Questionnaire, β partial regression coefficient, SE standard error, df degree of freedom
*Statistical significant
Multiple logistic analysis for association of an exercise habit with MDQ subscales during menstruation
| Variables | β | SE | Wald | df | Odds ratio | 95% CI | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Pain | − 0.027 | 0.033 | 0.669 | 1 | 0.413 | 0.973 | 0.912 | 1.039 |
| Concentration | − 0.013 | 0.045 | 0.083 | 1 | 0.773 | 0.987 | 0.904 | 1.078 |
| Behavioral change | − 0.096 | 0.024 | 15.345 | 1 | < 0.001* | 0.909 | 0.866 | 0.953 |
| Water retention | 0.005 | 0.045 | 0.013 | 1 | 0.909 | 1.005 | 0.920 | 1.098 |
| Negative affect | − 0.013 | 0.036 | 0.129 | 1 | 0.719 | 0.987 | 0.919 | 1.060 |
Variation inflation factor: pain, 2.270; concentration, 2.490; behavioral change, 2.920; water retention, 1.660; negative affect, 3.042
MDQ Menstrual Distress Questionnaire, β partial regression coefficient. SE standard error, df degree of freedom
*Statistical significant